Tuberculosis prophylaxis in HIV patients in Tomsk penitentiary system, Russia Source: Annual Congress 2008 - COPD and miscellaneous Year: 2008
Dynamics of MBT drug resistance in a specialized urban TB hospital (Saratov, Russia) Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II Year: 2012
Psychiatric disorders in MDR TB patients on the treatment regimens under DOTS-plus programme in Tomsk oblast penitentiary system Source: Eur Respir J 2001; 18: Suppl. 33, 513s Year: 2001
Improvement of TB epidemiological situation in Tomsk Oblast within the MDR-TB treatment program Source: Annual Congress 2008 - Asthma and miscellaneous disorders Year: 2008
Out-patient MDR-TB care in Moldova Source: International Congress 2015 – Management of TB: a patient focus Year: 2015
On-going TB treatment category for TB cases in Iasi county (Romania) Source: Annual Congress 2009 - Tuberculosis control Year: 2009
Dynamics analysis of MBT drug resistance to antitubercolosis second-line drugs (Saratov region hospital, Russia) Source: International Congress 2016 – Update on drug-resistant tuberculosis Year: 2016
Particularities of a cohort of preXDR / XDR TB patients treated with group 5 medication, hospitalized in MDR TB Department Institute of Pneumophtisiology Bucharest, Romania Source: International Congress 2016 – Update on drug-resistant tuberculosis Year: 2016
Success of the patient-oriented approach to MDR-TB treatment in Tomsk Oblast, Russia, 2000-2009 Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences Year: 2012
Effectiveness of national standardized and WHO regimens and risk factors of unfavorable outcomes in treatment of patients with MDR-TB in Novosibirsk Oblast, Russian Federation Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1 Year: 2014
Outcomes of MDR cases in Iasi county, Romania Source: Annual Congress 2005 - Resistant and multidrug resistant tuberculosis Year: 2005
New approaches to treatment of HIV-associated tuberculosis in penitentiary institutions of Belarus Source: Eur Respir J 2004; 24: Suppl. 48, 651s Year: 2004
MDR TB treatment results of GFATM program implementation in Tomsk, Russia Source: International Congress 2015 – Management of TB: a patient focus Year: 2015
Cost-effectiveness of the DOTS strategy of tuberculosis control in Iasi County, Romania Source: Eur Respir J 2003; 22: Suppl. 45, 39s Year: 2003
Rifampicin-resistant tuberculosis (RR-TB) in eastern Europe Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments Year: 2016
Study of prevalence of drug resistance in tuberculosis (TB) patients attending a tertiary care hospital at Mumbai Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis Year: 2016
A comparison of drug sensitivity pattern in category-I failure versus category-I relapse pulmonary TB patients attending a tertiary care hospital in South Punjab, Pakistan. Is WHO category-II ATT regimen appropriate? Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013
Case series of 83 XDR-TB patients in an urban hospital of Gujarat, India; an interim analysis Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015
Dynamics of MBT drug resistance in Saratov Region Hospital, Russia Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis Year: 2016
Estimating costs for treating patients with multi-drug resistant tuberculosis (MDR TB) under the regional tuberculosis control program, Tomsk (Russia) Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015